. Author manuscript; available in PMC: 2015 Dec 1.

Published in final edited form as: Blood Press Monit. 2014 Dec;19(6):353–358. doi: 10.1097/MBP.0000000000000075

Table 1.

Demographics and biomedical values in Baseline and final stages

Variables	N
Age (years)	N=18	52.9 ± 6.0
Sex (%women)	N=18	94.40%
Menopause (%)	N=8	50%
Antihypertensive medication (%)	N=3	22%
Hormone replacement therapy (%)	N=9	6%
	Baseline		Final		p-value
Body mass index (kg/m²)	N=18	31.56 ± 6.7	N=17	31.32 ± 6.94	0.7660
Body fat%	N=18	42.97 ± 9.11	N=16	41.04 ± 8.94	0.8921
Blood glucose (mg/dL)	N=18	94.33 ± 10.57	N=16	88.56 ± 9.86	0.0010
Serum creatinine (μmol/L)	N=18	0.86 ± 0.12	N=16	0.80 ± 0.13	0.0165
eGFR MDRD (mL/min/1.73m²)	N=18	93.23 ± 16.32	N=16	100.65 ± 23.95	0.0338
hs-CRP (mg/L)	N=18	4.93 ± 5.03	N=16	2.34 ± 2.09	0.0025
Total cholesterol (mg/dL)	N=18	194.17 ± 30.03	N=17	198.35 ± 31.62	0.5580
Triglycerides (mg/dL)	N=18	81.83 ± 31.35	N=17	74.18 ± 20.41	0.1474
VO_2max(ml/kg/min)	N=18	23.77 ± 4.54	N=18	26.07 ± 6.73	0.0364

Values are reported as means ± standard deviations.